Article Text

Download PDFPDF

FRI0281 Utility of morning sample of urine protein/creatinine ratio for assessment of proteinuria in patients with lupus nephritis
  1. H Zhang,
  2. J Liang,
  3. B Hua,
  4. L Sun
  1. Department of Rheumatology and Immunology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China


Background Proteinuria is the principal urinary biomarker for the screening of Lupus nephritis (LN) and for monitoring disease progression. 24-hour urine collection has been the foundation for monitoring disease activity in patients with LN, but collections are often inaccurate and inconvenient. The European League Against Rheumatism and American College of Rheumatology have recommended the urine protein/creatinine ratio (UPCR) for use in management of LN.

Objectives We aimed to evaluate the diagnostic accuracy of the morning sample of UPCR compared with 24-hour urine collection for the detection of proteinuria and to determine the UPCR for different proteinuria ranges in patients with LN.

Methods Three hundred and thirty seven LN patients were enrolled. The correlation between the UPCR in the morning spot urine samples and urinary protein excretion in the 24-hour collections was examined using the Pearson correlation test. The best cutoffs for UPCR predicting a 24-hour protein excretion were determined with the receiver operating characteristic curve (ROC).

Results It was found a good positive correlation between the UPCR and 24-hour protein excretion, with a correlation coefficient (r) of 0.891 (Fig 1). The best cutoff which gave the maximum area under the curve was 0.44 for 0.5 g, 0.92 for 1.0 g, 2.21 for 2.0 g, 2.70 for 3.0 g, 3.49 for 4.0 g and 4.59 for 5.0g.

Conclusions The UPCR can be used as a screening test as a good predictor for proteinuria of LN patients. Also, UPCR is a valuable tool with which to monitor disease progression.


  1. Bertsias GK, Tektonidou M, Amoura Z, et al. Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis. Ann Rheum Dis 2012; 71: 1771–82.

  2. Renal Disease Subcommittee of the American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Response Criteria. The American College of Rheumatology response criteria for proliferative and membranous renal disease in systemic lupus erythematosus clinical trials. Arthritis Rheum 2006; 54: 421–32.

  3. Medina-Rosas J, Yap KS, Anderson M, et al. Utility of Urinary Protein-Creatinine Ratio and Protein Content in a 24-Hour Urine Collection in Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis. Arthritis Care Res (Hoboken) 2016; 68: 1310–9.


Disclosure of Interest None declared

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.